IN-VITRO ANTIBACTERIAL ACTIVITY AND PHYTOCHEMICAL SCREENING OF ETHANOLIC EXTRACT OF EUPHORBIA PROSTRATA

The present invention relates to the antibacterial potential of Euphorbia Prostrata's ethanolic extract against Bacillus subtilis, Escherichia coli, Bacillus thuringiensis, and Pseudomonas aeruginosa at concentrations of 30mg/ml, 50mg/ml, and 70mg/ml. Phytochemical screening reveals the presence of carbohydrates, proteins, flavonoids, and other bioactive compounds. The highest zone of inhibition occurs in B. thuringiensis (13mm at 70mg/ml), followed by E. coli (12mm at 70mg/ml) and B. subtilis (11mm at 70mg/ml), with the least in P. aeruginosa (9mm at 70mg/ml). The study demonstrates a concentration-dependent increase in antibacterial efficacy. Euphorbia Prostrata emerges as a promising medicinal plant, showcasing diverse properties with potential applications in traditional medicine. Further research is warranted to unlock additional therapeutic attributes and medical applications.